Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “United Therapeutics Corporation”

95 pharma patents match "United Therapeutics Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 95
Index total 30,257
Page 2 / 4

Quick answer

This filtered view shows 95 pharmaceutical patents matching "United Therapeutics Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

95 results for “United Therapeutics Corporation” · 30,257 patents in full index Clear search

  1. US 11001551

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted May 11, 2021 · Expires May 6, 2041

    granted
  2. US 10947177

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  3. US 10946047

    Extracellular vesicles with enhanced potency

    United Therapeutics Corporation · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted
  4. US 10842823

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  5. US 10716793

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  6. US 10695308

    Inhalation formulations of treprostinil

    United Therapeutics Corporation · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted
  7. US 10548863

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  8. US 10494327

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  9. US 10478410

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  10. US 10376525

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  11. US 10322099

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  12. US 10167247

    Solid forms of treprostinil

    United Therapeutics Corporation · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted
  13. US 10154965

    Osmotic drug delivery system

    United Therapeutics Corporation · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted
  14. US 10093641

    Process for making beraprost

    United Therapeutics Corporation · Granted Oct 9, 2018 · Expires Oct 4, 2038

    granted
  15. US 10080730

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  16. US 10076505

    Inhalation formulations of Treprostinil

    United Therapeutics Corporation · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted
  17. US 10071123

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    United Therapeutics Corporation · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  18. US 10016463

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted
  19. US 9988334

    Salts of treprostinil

    United Therapeutics Corporation · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  20. US 9878972

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted
  21. US 9822057

    Solid forms of treprostinil

    United Therapeutics Corporation · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted
  22. US 9765047

    Process for making beraprost

    United Therapeutics Corporation · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  23. US 9758465

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  24. US 9713599

    Parenteral formulations of treprostinil

    United Therapeutics Corporation · Granted Jul 25, 2017 · Expires Jul 20, 2037

    granted